The Risk of recurrence in prostate cancer
by: Fritz Frei
Prostate cancer disease
Prostate cancer - the most common form of cancer in men is Prostate cancer, the second leading cause of cancer death. The Main risk factors include age (incidence increases in men over the age of 65 years). It is more prevalent in the western world and about 10% of cases can be linked to family history. The recurrance Rate of the prostate cancer is high.
Mostly, the Prostate cancer is a continuum; progressing through localized, locally advanced, advanced and hormone-refractory stages In general it is a slow growing cancer. He is primarily under hormonal control i.e. testosterone. The choice of treatments which include watchful waiting, surgery (prostatectomy), radiotherapy, hormonal therapy and chemotherapy are dependent on the stage of disease.
1. Most important, that If detected early, using PSA determination, DRE examination and biopsies, and treated appropriately, survival rates are excellent.
2. The most critical focus for the treatment of prostate cancer is to treat those cancers where it is necessary.
3. The Decisions about the best management of prostate cancer can be very complex and depend upon the:
- Pathology of the cancer (unlike other cancers, prostate cancer often progresses very slowly)
- The impact that treatment can have on quality of life, including sexual activity
- Stage of the disease (non-metastatic (localized or locally advanced), metastatic or hormone refractory)
- Age and general health of the patients at diagnosis
- Patient’s preference for treatment
- PSA at diagnosis
4. The treatment options for prostate cancer are:
- Deferred treatment often called ‘watchful waiting’ or 'active surveillance'
- Surgery – Radical Prostatectomy
- Radiotherapy – External Beam and/or Brachytherapy
-Hormonal (endocrine) therapy – Androgen Ablation e.g. anti-androgens, medical castration (LHRHa) or surgical castration
- Palliative Therapy e.g. chemotherapy
- Investigational Therapies
Prostate Cancer Recurrence Rates ***
Prostate cancer is now detected at earlier stages due to heightened awareness and improved screening techniques. Despite definitive therapy, cancer cells may remain and can go undetected for years until they develop into metastatic disease. The risk of recurrence is high, suggesting there is a need to improve treatment approaches. Therefore, it is important to predict pathological stage and risk of disease recurrence early, so that appropriate treatment and/or monitoring can be initiated. The result's of all new treatments will bring us in the future the chance of a lower prostate recurrance.
**You can inform you about the recurrence Rates on:
This gives you an overview with a study case – and the results.
Latest Cancer News:
Cancer blood test moves step closer
A British team of researchers has developed what might be a simple blood test for cancer, scientists from the University of Bradford say. t Cancer
Many more people are beating Cancer now than ever, a local woman obtaining her doctorate is trying to develop what sort of treatment patients should receive once they're in remission.I spoke with Sana Keller recently regarding her work....(Melinda Bolton, Reporter) "After working for years as a nurse, Sana Keller is hoping to finish off her doctorate by giving some cancer survivors lifestyle ... Eating For A Cause, and Standing Up To Cancer
Since its founding in 2008, SU2C has emerged as one of the largest and most innovative anti-cancer programs. Cause marketing is a serious issue, and business... Your Cat's Poop Could One Day Treat Cancer
A microscopic organism that lives in cat poop could one day be used as a cancer treatment, researchers say. Toxoplasma gondii is a single-celled parasite that lives in cats' intestines, but can infect other animals and people as well. Now, researchers are aiming to harness the immune response triggered by the parasite and direct it to attacking tumors. "We know [that] biologically, this parasite ... Antioxidant Supplements Don't Fight Cancer, Research Suggests
Antioxidants ? chemicals found natural foods and man-made pills that may prevent certain types of cell damage ? have been touted for their supposed anti-cancer properties, but some research suggests these substances may not lower cancer risk and, in some cases, may even increase it. In a new paper, published July 10 in the New England Journal of Medicine, researchers analyzed previous studies on ... Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center
LOS ANGELES -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TILs), today announced that it has ... Long-Shot Breast Cancer Drug Now Promises Fortune, but Not for Big Pharma
Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire. In 2011, the Puma Biotechnology Inc. chief executive officer leveraged the industry connections he gained from his past at a previous company to license an obscure breast cancer drug from Pfizer Inc. Now his latest company may have a bestseller, thanks to a trial Pfizer started ... New drug target can break down cancer's barrier against treatment
( Cancer Research UK ) Scientists have found that a molecule -- focal adhesion kinase -- signals the body to repair itself after chemotherapy or radiotherapy, which kill cancer cells by damaging DNA. Clearing cells to prevent cervical cancer
A novel approach to preventing cervical cancer has been described by researchers, based on findings showing successful reduction in the risk of cervical cancer after removal of a discrete population of cells in the cervix. The findings come from a study that looked at squamocolumnar junction cells, or SCJ cells. These cells reside in the cervical canal and have been implicated as the origins of ... Research and Markets: Cancer Immunotherapy Market & Clinical Pipeline Insight 2014
Research and Markets has announced the addition of the "Cancer Immunotherapy Market & Clinical Pipeline Insight" repo Michael Douglas talks cancer battle with wife Catherine Zeta-Jones by his side - New York Daily News